Fournier Gangrene Clinical Trial
Official title:
Fournier's Gangrene as a Rare Complication in Patient With Uncontrolled Type 2 Diabetes Treated With Surgical Debridement: a Case Report and Literature Review
A 66-year-old man, with a history of uncontrolled type 2 diabetes, obesity with BMI 38, chronic kidney failure and chronic heart failure, was admitted to the Emergency Department with a large area of necrosis involving the perineal and perianal regions.
Fournier's gangrene is a potentially fatal emergency condition, supported by an infection of perineal and perianal region, characterized by necrotizing fasciitis with a rapid spread to fascial planes. FG, usually due to compromised host, may be sustained by many microbial pathogens. A 66-year-old man, with a history of uncontrolled type 2 diabetes, obesity with BMI 38, chronic kidney failure and chronic heart failure, was admitted to the Emergency Department with a large area of necrosis involving the perineal and perianal regions. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05116956 -
SKin and Soft Tissue Necrotizing INfections in the Intensive Care Unit: a Prospective Multi-national Cohort Study
|
||
Completed |
NCT03443544 -
Fournier's Gangrene and the Origin of the Infection as a Prognostic of Morbidity and Mortality, an Analysis of 121 Patients
|
N/A | |
Completed |
NCT05529628 -
The Immunological Differences Between Fournier Gangrene and Perianal Abscess
|
||
Completed |
NCT04983056 -
Management of Fournier Gangrene at Ibn Rochd University Hospital Center
|
||
Completed |
NCT02180906 -
Biomarkers in Patients With Flesh-eating Bacterial Infections
|
N/A | |
Completed |
NCT03147352 -
Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study
|
||
Completed |
NCT02501382 -
Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment
|
||
Completed |
NCT02111161 -
Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
|
Phase 2 |